METHOD FOR DETERMINING THE EFFICIENCY OF COMBINED THERAPY ulcerative colitis

摘要

A method for determining the effectiveness of combined therapy of ulcerative colitis by immunological studies, characterized by determining the level of transient increase antibodies to infliximab and transient increase in antibody levels from 70 to 95.2 ng / ml, and reducing to infliximab 0.3-0.7 ug / ml administered azathioprine and complex therapy of ulcerative colitis is considered effective.